Whittier Trust’s Ascendis Pharma A/S ASND Stock Holding History

Whittier Trust’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-87	Closed	-$9K	–	1628
2022 Q3	$9K	Hold	87	–	–	﹤0.01%	1350
2022 Q2	$8K	Hold	87	–	–	﹤0.01%	1350
2022 Q1	$10K	Buy	+87	New	+$10.1K	﹤0.01%	1328
2021 Q3	–	Sell	-33	Closed	-$4K	–	1492
2021 Q2	$4K	Hold	33	–	–	﹤0.01%	1376
2021 Q1	$4K	Buy	+33	New	+$5.01K	﹤0.01%	1367

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Whittier Trust's ASND Position: Q4 2022 in Review

Whittier Trust sold out of Ascendis Pharma A/S (ASND) in Q4 2022, closing a stake of 87 shares — an estimated $9K sold.

Whittier Trust first reported a position in ASND in Q1 2021 and held it in 5 quarters. The position peaked at $10K in Q1 2022. 187 funds tracked by Wall St. Rank hold ASND as of Q4 2022.

Whittier Trust reported no remaining Ascendis Pharma A/S position as of Q4 2022 after selling out during the quarter.
Whittier Trust sold 87 Ascendis Pharma A/S shares in Q4 2022, an estimated $9K.
Whittier Trust first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 5 quarters.
Whittier Trust's Ascendis Pharma A/S position peaked at $10K in Q1 2022.
187 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2022.

Based on Whittier Trust's 13F filing for Q4 2022, filed 25 Jan 2023.